Literature DB >> 1829808

FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro.

B M Kacinski1, K A Scata, D Carter, L D Yee, E Sapi, B L King, S K Chambers, M A Jones, M H Pirro, E R Stanley.   

Abstract

The expression in vivo of FMS transcripts and antigen by neoplastic epithelial cells was demonstrated immunohistochemically or by in situ hybridization in sixteen of seventeen human breast carcinoma specimens and one case of sclerosing adenosis. Expression of CSF-1 receptor (FMS) transcripts and protein was also observed in vitro in two or three breast carcinoma-derived cell lines and was dramatically increased by dexamethasone, a potent glucocorticoid and inducer of mammary epithelial cell differentiation. Immunohistochemical staining with an anti-CSF-1 antibody identified neoplastic epithelial cell co-expression of fms and CSF-1 antigens in more than one-third of the fms-positive invasive carcinoma specimens. These results suggest that autocrine and paracrine interactions of the lymphohematopoietic cytokine CSF-1 and its receptor may participate in the biology of human mammary neoplasms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1829808

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

1.  Posttranscriptional suppression of proto-oncogene c-fms expression by vigilin in breast cancer.

Authors:  Ho-Hyung Woo; Xiaofang Yi; Tiffany Lamb; Ina Menzl; Terri Baker; David J Shapiro; Setsuko K Chambers
Journal:  Mol Cell Biol       Date:  2010-10-25       Impact factor: 4.272

2.  Both cell-surface and secreted CSF-1 expressed by tumor cells metastatic to bone can contribute to osteoclast activation.

Authors:  Kader Yagiz; Susan R Rittling
Journal:  Exp Cell Res       Date:  2009-05-08       Impact factor: 3.905

3.  Mena invasive (MenaINV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer.

Authors:  Evanthia T Roussos; Michele Balsamo; Shannon K Alford; Jeffrey B Wyckoff; Bojana Gligorijevic; Yarong Wang; Maria Pozzuto; Robert Stobezki; Sumanta Goswami; Jeffrey E Segall; Douglas A Lauffenburger; Anne R Bresnick; Frank B Gertler; John S Condeelis
Journal:  J Cell Sci       Date:  2011-07-01       Impact factor: 5.285

Review 4.  Kinase inhibitors in cancer therapy: a look ahead.

Authors:  H H Sedlacek
Journal:  Drugs       Date:  2000-03       Impact factor: 9.546

5.  Circulating levels of the macrophage colony stimulating factor CSF-1 in primary and metastatic breast cancer patients. A pilot study.

Authors:  S M Scholl; R Lidereau; A de la Rochefordière; C C Le-Nir; V Mosseri; C Noguès; P Pouillart; F R Stanley
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

6.  Granulocyte-colony stimulating factor promotes invasion by human lung cancer cell lines in vitro.

Authors:  X H Pei; Y Nakanishi; K Takayama; J Yatsunami; F Bai; M Kawasaki; K Wakamatsu; N Tsuruta; K Mizuno; N Hara
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

7.  Correlation of tumor phenotype with c-fms proto-oncogene expression in an in vivo intraperitoneal model for experimental human breast cancer metastasis.

Authors:  Eugene P Toy; Nathalie Bonafé; Asim Savlu; Caroline Zeiss; Wenxin Zheng; Maryann Flick; Setsuko K Chambers
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

Review 8.  Role of CSF-1 in progression of epithelial ovarian cancer.

Authors:  Setsuko K Chambers
Journal:  Future Oncol       Date:  2009-11       Impact factor: 3.404

Review 9.  Macrophage diversity in renal injury and repair.

Authors:  Sharon D Ricardo; Harry van Goor; Allison A Eddy
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

10.  Invasion of human breast cancer cells in vivo requires both paracrine and autocrine loops involving the colony-stimulating factor-1 receptor.

Authors:  Antonia Patsialou; Jeffrey Wyckoff; Yarong Wang; Sumanta Goswami; E Richard Stanley; John S Condeelis
Journal:  Cancer Res       Date:  2009-12-15       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.